ETISENSE continues to expand access to its solutions internationally
Lyon & Vitrolles, France – June 2025 — Etisense, a French biomedical engineering company specializing in wearable telemetry for preclinical research, is proud to announce a new partnership with Bioseb, a leading supplier of preclinical instruments for neuroscience, pain, and behavioural studies.
Under this agreement, Bioseb will distribute the DECRO solution in Europe (excluding the UK and Eastern Europe, already covered by other distributors) and North America under non-exclusive terms.
DECRO, Etisense’s flagship product, is a non-invasive telemetry system that enables the continuous monitoring of ECG, respiratory function, and activity in small to large animals — without surgery, shaving, or restraint. The system is already adopted for phenotyping disease models, safety pharmacology, and animal welfare monitoring.
Bioseb brings to this partnership its deep expertise and established networks across neuroscience, pain, behavioural research, and broader in vivo physiology applications, where non-invasive cardiorespiratory monitoring is increasingly valuable.
"This collaboration opens new doors for Etisense in North America and beyond," said Corinne Simon, Chief Business Officer at Etisense. "Bioseb is a well-established player in our field, and their presence will significantly accelerate our business development internationally."
"We are pleased to expand our portfolio with the DECRO solution from Etisense," said Anne Desevré, General Director of Bioseb. "This high-quality telemetry system complements our offering perfectly and meets the growing demand for refined physiological monitoring tools."
This partnership illustrates how two French companies can combine their strengths to create value in global biomedical research markets, advancing both scientific performance and ethical practices in preclinical studies.
For more information about this partnership, please contact:
contact@etisense.com
info@bioseb.com
